Current updates on adaptive immune response by B cell and T cell stimulation and therapeutic strategies for novel coronavirus disease 2019 (COVID-19) treatment
The prevalence of COVID-19 continues to rise with more than 114,315,846 million confirmed cases and 2,539,427 deaths worldwide by 3 March 2021 and this number kept on increasing day by day. There is no clear therapeutic treatment or vaccine available for COVID-19 till date and by seeing such a high...
Main Authors: | Neeraj Pal, Anil Kumar Mavi, Sundip Kumar, Umesh Kumar, Maya Datt Joshi, Rohit Saluja |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S240584402100997X |
Similar Items
-
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
by: Bo Diao, et al.
Published: (2020-05-01) -
Therapeutic potential of different types of stem cells
by: Vinod Kumar, et al.
Published: (2014-10-01) -
Improved therapeutics of modified mesenchymal stem cells: an update
by: Dickson Kofi Wiredu Ocansey, et al.
Published: (2020-01-01) -
Mesenchymal stem cell infusion as a promising therapeutic approach to treat coronavirus disease 2019 patients
by: Nihal AlMuraikhi
Published: (2020-01-01) -
The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019
by: Maurice A. Canham, et al.
Published: (2020-09-01)